With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 240 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Belgium Law Firm - Bird & Bird
Chambers UK, 2018
Chambers Europe-wide, 2018
Legal 500, 2018
Chambers Asia-Pacific, 2018
Chambers Global- wide, 2018
Ewan explored the legal issues which arise at various stages of the lifecycle of a medical device; from product concept, though prototyping, testing, refinement, manufacture, marketing and placing on the market.
The Supreme Court has confirmed that a patent for a dosage regime of a drug used to treat erectile dysfunction (ED) was obvious over the prior art.
On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").
Last night we were awarded 'Global Patent Firm of the Year' at the 5th annual Who's Who Legal Awards in London. This achievement showcases the international strength and quality of our teams and confirms our ...
We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes
The capital markets experts based in London have advised on four placings which closed within the same week
There are no forthcoming events for this area. Please click on the button below to view past events.
Click here to view our report from #MedTechExpo 2019:
Our team in action at the #MedTechExpo in Birmingham! https://t.co/uymQN1mQfs
'Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines'. Click here to see Domi… https://t.co/LNyUtxzCEE